Daniel D Mikol Selected Research

Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)

1/2021	Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study.
1/2020	Vascular safety of erenumab for migraine prevention.
1/2019	Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
1/2019	Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.
5/2018	A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina.
1/2018	ARISE: A Phase 3 randomized trial of erenumab for episodic migraine.
1/2018	Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab.
11/2017	A Controlled Trial of Erenumab for Episodic Migraine.
9/2017	Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel D Mikol Research Topics

Disease

31	Migraine Disorders (Migraine) 01/2022 - 09/2017
9	Headache (Headaches) 11/2021 - 09/2017
7	Multiple Sclerosis 01/2017 - 03/2004
3	Relapsing-Remitting Multiple Sclerosis 01/2017 - 01/2008
2	Nasopharyngitis 01/2021 - 11/2019
2	Neoplasms (Cancer) 02/2006 - 12/2004
2	Cardiotoxicity 01/2006 - 12/2004
1	Pain (Aches) 12/2021
1	Secondary Headache Disorders 07/2021
1	Back Pain (Backache) 01/2021
1	Constipation 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Prescription Drug Overuse 01/2019
1	Congenital Abnormalities (Deformity) 12/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2018
1	Stable Angina 05/2018
1	Body Weight (Weight, Body) 01/2017
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2006
1	Cardiomyopathies (Cardiomyopathy) 12/2004
1	Urinary Tract Infections (Urinary Tract Infection) 12/2004
1	Amenorrhea 12/2004
1	Alopecia (Baldness) 12/2004
1	Infections 12/2004
1	Leukemia 12/2004
1	Nausea 12/2004
1	Leukopenia 12/2004

Drug/Important Bio-Agent (IBA)

29	erenumabIBA 01/2022 - 09/2017
10	Monoclonal AntibodiesIBA 01/2021 - 11/2017
9	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2021 - 09/2017
4	Calcitonin Gene-Related PeptideIBA 01/2019 - 01/2018
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2006 - 12/2004
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2006 - 12/2004
1	Tryptamines (Triptans)IBA 07/2021
1	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2021
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 12/2019
1	Oral ContraceptivesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	naratriptan FDA LinkGeneric 12/2018
1	sumatriptan-naproxen FDA Link 12/2018
1	Sumatriptan (Imigran)FDA LinkGeneric 12/2018
1	IntegrinsIBA 01/2017
1	Natalizumab (Tysabri)FDA Link 01/2017
1	AntibodiesIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	TACI receptor-IgG Fc fragment fusion proteinIBA 04/2014
1	GadoliniumIBA 04/2014
1	Interferon beta-1a FDA Link 10/2008
1	Glatiramer Acetate (Copaxone)FDA Link 10/2008
1	Myelin ProteinsIBA 11/2006
1	Peptides (Polypeptides)IBA 11/2006
1	Immunoglobulin E (IgE)IBA 11/2006
1	GTP Phosphohydrolases (GTPases)IBA 02/2006
1	CaveolinsIBA 02/2006
1	Neurofibromin 1 (Neurofibromin)IBA 02/2006
1	Proteins (Proteins, Gene)FDA Link 02/2006
1	Caveolin 1IBA 02/2006
1	AnthracyclinesIBA 12/2004
1	EnzymesIBA 12/2004
1	Sildenafil Citrate (Viagra)FDA Link 03/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2008
2	Subcutaneous Injections 11/2019 - 04/2014
1	Immunomodulation 04/2014